Vaccine effectiveness (VE) against COVID-related hospitalization was 40% (95% confidence interval [CI], 27% to 51%) through ...

Sustained protection through 6 months, but effectiveness slipped as newer strains emerged ...

Recent global challenges posed by the COVID-19 pandemic have accelerated innovations in mechanical ventilation technology, with research efforts focused on both invasive and non-invasive modalities to ...

A meta-trial of randomized clinical studies conducted in 6 countries suggests that the use of inhaled heparin dramatically reduced the risk of intubation, death, and in-hospital death in hospitalized ...

The team’s study, “COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation," was recently published in Critical Care. A collaborative study ...

Please provide your email address to receive an email when new articles are posted on . Half of participants received an initial dose of COVID-19 vaccine, but only 23% received a booster. Participants ...

In the early evening of March 7, 2020, I was on my cellphone in an airport terminal, telling a friend that I was afraid to write an article that risked ruining my journalistic reputation. I had been ...

COVID-19 patients who received Humanigen’s monoclonal antibody lenzilumab were 54 percent more likely to survive without needing ventilation over a 28-day period compared to patients who received a ...

Every time we open our mouth we exhale particles that may contain the virus. As states begin to adjust to a new normal and people start spending more time indoors, experts and local officials are ...